EXAMINATION THE ABILITY TO EARLY DIAGNOSE HCC BY COMBINING THREE BIOMARKERS TECHNOLOGY DEVELOPED BY WAKO, AND THEIR RELEVANCE TO CIRRHOTIC OF PATIENTS WITH VARIOUS BACKGROUNDS AND THE ISRAELI POPULATION.: